SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19.
作者信息
Pirola Carlos J, Sookoian Silvia
机构信息
School of Medicine, Institute of Medical Research A Lanari, University of Buenos Aires, Buenos Aires, Argentina.
Department of Molecular Genetics and Biology of Complex Diseases, Institute of Medical Research (IDIM), National Scientific and Technical Research Council (CONICET)-University of Buenos Aires, Buenos Aires, Argentina.
出版信息
Liver Int. 2020 Aug;40(8):2038-2040. doi: 10.1111/liv.14500. Epub 2020 Jun 10.
Abstract
摘要
相似文献
1
SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19.
Liver Int. 2020 Aug;40(8):2038-2040. doi: 10.1111/liv.14500. Epub 2020 Jun 10.
2
ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19.
J Allergy Clin Immunol. 2020 Jul;146(1):208-211. doi: 10.1016/j.jaci.2020.05.013. Epub 2020 May 22.
3
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191.
4
Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
Arch Toxicol. 2020 Dec;94(12):4037-4041. doi: 10.1007/s00204-020-02869-1. Epub 2020 Aug 17.
5
Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
Int J Mol Sci. 2020 Aug 20;21(17):6000. doi: 10.3390/ijms21176000.
6
Structural and functional modelling of SARS-CoV-2 entry in animal models.
Sci Rep. 2020 Sep 28;10(1):15917. doi: 10.1038/s41598-020-72528-z.
7
TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.
J Dent Res. 2020 Sep;99(10):1120-1121. doi: 10.1177/0022034520933589. Epub 2020 Jun 1.
8
Targeting TMPRSS2 in SARS-CoV-2 Infection.
Mayo Clin Proc. 2020 Sep;95(9):1989-1999. doi: 10.1016/j.mayocp.2020.06.018. Epub 2020 Jul 19.
9
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Med Hypotheses. 2020 Oct;143:109893. doi: 10.1016/j.mehy.2020.109893. Epub 2020 May 30.
10
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
Mol Biol Rep. 2020 Jun;47(6):4383-4392. doi: 10.1007/s11033-020-05478-4. Epub 2020 May 14.
引用本文的文献
1
Assessment of serum biomarker changes following the COVID-19 pandemic and vaccination: a cohort study in Sylhet, Bangladesh.
Front Public Health. 2025 Feb 21;13:1435930. doi: 10.3389/fpubh.2025.1435930. eCollection 2025.
2
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study.
Viruses. 2024 Dec 30;17(1):40. doi: 10.3390/v17010040.
3
Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2.
Int J Mol Sci. 2024 Aug 30;25(17):9419. doi: 10.3390/ijms25179419.
4
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.
Hepatol Forum. 2024 Jul 2;5(3):139-149. doi: 10.14744/hf.2023.2023.0025. eCollection 2024.
5
Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.
World J Gastroenterol. 2024 Jun 14;30(22):2866-2880. doi: 10.3748/wjg.v30.i22.2866.
6
Spectrum of COVID-19 induced liver injury: A review report.
World J Hepatol. 2024 Apr 27;16(4):517-536. doi: 10.4254/wjh.v16.i4.517.
7
COVID-19 in liver transplant recipients.
J Liver Transpl. 2021 Jul-Sep;3:100026. doi: 10.1016/j.liver.2021.100026. Epub 2021 Jul 22.
8
Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage.
World J Hepatol. 2024 Jan 27;16(1):1-11. doi: 10.4254/wjh.v16.i1.1.
9
Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study.
BMC Gastroenterol. 2023 Aug 8;23(1):271. doi: 10.1186/s12876-023-02907-z.
10
An Updated Systematic Review and Meta-Analysis of the Association between the De Ritis Ratio and Disease Severity and Mortality in Patients with COVID-19.
Life (Basel). 2023 Jun 5;13(6):1324. doi: 10.3390/life13061324.
本文引用的文献
1
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Gastroenterology. 2020 Jul;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065. Epub 2020 Apr 3.
2
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.
Liver Int. 2020 Sep;40(9):2095-2103. doi: 10.1111/liv.14455. Epub 2020 Apr 28.
3
Liver injury in COVID-19: management and challenges.
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.
4
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations.
Nat Commun. 2018 Oct 22;9(1):4383. doi: 10.1038/s41467-018-06318-7.
5
SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases.
Hepatology. 2004 Feb;39(2):302-10. doi: 10.1002/hep.20111.
Zotero 插件